Home
About
Directory
Promoted Listings
Purchase Data
Drug Pipelines
Data Licensing
Newsletter
Contact
TyrNovo
is defunct.
Bought by Kitov Therapeutics, Jan 2017, $2M + $1.8M stock
------------------
If you believe any of this information is incorrect, please
let us know
.